Oncomatryx

Oncomatryx Biopharma is a biopharmaceutical company focused on the tumor microenvironment. It develops drugs and diagnostic devices that target the tumor stroma. Its Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells, and an extracellular matrix that promote tumor invasiveness, drug resistance, and immunosuppression.